A critical breakthrough in cancer study is emerging with the use of nanobodies to restore dysfunctional p53. This essential malignant protector protein is frequently inactivated in several forms of malignancies, https://johsocial.com/story12666735/vhh-fragments-reactivate-tumor-suppressor-p53-the-potential-hope-for-tumor-management